Patents by Inventor Manish Gopaldas Gangrade

Manish Gopaldas Gangrade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210040116
    Abstract: The present invention relates to new polymorphs of dolutegravir sodium and processes for the preparation of the new polymorphs of dolutegravir sodium. The present invention also provides pharmaceutical compositions comprising these new polymorphs, and medical uses of the polymorphs.
    Type: Application
    Filed: September 7, 2017
    Publication date: February 11, 2021
    Inventors: Dharmaraj Ramachandra RAO, Geena MALHOTRA, Manjinder Singh PHULL, Ashwini Amol SAWANT, Amit NAIK, Manish Gopaldas GANGRADE, Shashirekha KANATHALA
  • Publication number: 20200131211
    Abstract: The present invention relates to certain acid salts of (((1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)(phenoxy) phosphoryloxy)methyl pivalate of Formula (I), to processes for their preparation; to pharmaceutical compositions comprising such compounds, and methods of treating a disease which responds to inhibition of nucleotide reverse transcriptase activity.
    Type: Application
    Filed: March 16, 2018
    Publication date: April 30, 2020
    Inventors: Manjinder Singh PHULL, Ashwini Amol SAWANT, Dharmaraj Ramachandra RAO, Geena MALHOTRA, Manish Gopaldas GANGRADE
  • Patent number: 10300044
    Abstract: Amorphous methyl((1S)-1-(((2S)-2-(5-(4?-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl) carbamate free base, amorphous methyl((1S)-1-(((2S)-2-(5-(4?-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl) carbamate dihydrochloride, methods of making them, and pharmaceutical compositions containing them.
    Type: Grant
    Filed: December 24, 2015
    Date of Patent: May 28, 2019
    Assignee: Cipla Limited
    Inventors: Dharmaraj Ramachandra Rao, Geena Malhotra, Manjinder Singh Phull, Shashirekha Kanathala, Manish Gopaldas Gangrade
  • Patent number: 10301282
    Abstract: The present invention relates to a novel polymorph of nilotinib hydrochloride (Form X), to processes for its preparation, to pharmaceutical compositions containing the same and to its use in medicine.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: May 28, 2019
    Assignee: Cipla Limited
    Inventors: Dharmaraj Ramachandra Rao, Geena Malhotra, Srinivas Laxminarayan Pathi, Venugopalarao Chinimilli, Manish Gopaldas Gangrade
  • Publication number: 20180111915
    Abstract: The present invention relates to a novel polymorph of nilotinib hydrochloride (Form X), to processes for its preparation, to pharmaceutical compositions containing the same and to its use in medicine.
    Type: Application
    Filed: March 21, 2016
    Publication date: April 26, 2018
    Applicant: Cipla Limited
    Inventors: Dharmaraj Ramachandra RAO, Geena MALHOTRA, Srinivas Laxminarayan PATHI, Venugopalarao CHINIMILLI, Manish Gopaldas GANGRADE
  • Publication number: 20170354644
    Abstract: Amorphous methyl((1S)-1-(((2S)-2-(5-(4?-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl) carbamate free base, amorphous methyl((1S)-1-(((2S)-2-(5-(4?-(2-((2S)-1-((2S)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)-4-biphenylyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) carbonyl)-2-methylpropyl) carbamate dihydrochloride, methods of making them, and pharmaceutical compositions containing them.
    Type: Application
    Filed: December 24, 2015
    Publication date: December 14, 2017
    Inventors: Dharmaraj Ramachandra RAO, Geena MALHOTRA, Manjinder Singh PHULL, Shashirekha KANATHALA, Manish Gopaldas GANGRADE
  • Patent number: 8383627
    Abstract: Crystalline Form IV of doxazosin mesylate, a process for its preparation and uses thereof.
    Type: Grant
    Filed: July 10, 2008
    Date of Patent: February 26, 2013
    Assignee: CIPLA Limited
    Inventors: Rajendra Narayanrao Kankan, Dharmaraj Ramachandra Rao, Manish Gopaldas Gangrade, Shrikant Suresh Mudgal
  • Patent number: 8349863
    Abstract: The invention relates to a novel crystalline form of topotecan hydrochloride, and methods of making the same. The characteristic XRPD pattern and FT-IT patterns are shown in FIGS. 1 and 2.
    Type: Grant
    Filed: October 10, 2006
    Date of Patent: January 8, 2013
    Assignee: Cipla Limited
    Inventors: Srinivas Laxminarayan Pathi, Shashi Rekha Kanathala, Manish Gopaldas Gangrade, Rajendra Narayanrao Kankan, Dharmaraj Ramachandra Rao
  • Patent number: 8247434
    Abstract: Anhydrous crystalline fexofenadine hydrochloride Form C, crystalline fexofenadine acetate monohydrate Form D, crystalline fexofenadine acetate dihydrate Form E and crystalline fexofenadine free base monohydrate Form F, processes of preparing the same, pharmaceutical compositions thereof, therapeutic uses thereof and methods of treatment therewith.
    Type: Grant
    Filed: November 19, 2008
    Date of Patent: August 21, 2012
    Assignee: Cipla Limited
    Inventors: Dharmaraj Ramachandra Rao, Rajendra Narayanrao Kankan, Manish Gopaldas Gangrade, Dilip Ramdas Birari
  • Publication number: 20110034477
    Abstract: Crystalline Form IV of doxazosin mesylate, a process for its preparation and uses thereof.
    Type: Application
    Filed: July 10, 2008
    Publication date: February 10, 2011
    Applicant: CIPLA LIMITED
    Inventors: Rajendra Narayanrao Kankan, Dharmaraj Ramachandra Rao, Manish Gopaldas Gangrade, Shrikant Suresh Mudgal
  • Publication number: 20090221830
    Abstract: Anhydrous crystalline fexofenadine hydrochloride Form C, crystalline fexofenadine acetate monohydrate Form D, crystalline fexofenadine acetate dihydrate Form E and crystalline fexofenadine free base monohydrate Form F, processes of preparing the same, pharmaceutical compositions thereof, therapeutic uses thereof and methods of treatment therewith.
    Type: Application
    Filed: November 19, 2008
    Publication date: September 3, 2009
    Applicant: Cipla Limited
    Inventors: Dharmaraj Ramachandra RAO, Rajendra Narayanrao KANKAN, Manish Gopaldas GANGRADE, Dilip Ramdas BIRARI
  • Patent number: 7470789
    Abstract: Anhydrous crystalline fexofenadine hydrochloride Form C, crystalline fexofenadine acetate monohydrate Form D, crystalline fexofenadine acetate dihydrate Form E and crystalline fexofenadine free base monohydrate Form F, processes of preparing the same, pharmaceutical compositions thereof, therapeutic uses thereof and methods of treatment therewith.
    Type: Grant
    Filed: August 25, 2004
    Date of Patent: December 30, 2008
    Assignee: Cipla Limited
    Inventors: Dharmaraj Ramachandra Rao, Rajendra Narayanrao Kankan, Manish Gopaldas Gangrade, Dilip Ramdas Birari